EP 3565536 A1 20191113 - PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF
Title (en)
PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON STOFFWECHSELSYNDROM, INFEKTIONSKRANKHEITEN UND KOMPLIKATIONEN DAVON
Title (fr)
COMPOSITION PHARMACEUTIQUE UTILISÉE POUR TRAITER LES TROUBLES DU SYNDROME MÉTABOLIQUE, LES MALADIES INFECTIEUSES, ET LEURS COMPLICATIONS.
Publication
Application
Priority
- FR 1770014 A 20170107
- FR 1771175 A 20171107
- IB 2017057731 W 20171207
Abstract (en)
[origin: WO2018127748A1] The present invention relates to a pharmaceutical composition, characterized in that it comprises, as active ingredient, a combination of d-limonene, lupeol and a pharmaceutically active agent selected from cinnamaldehyde, epicatechin, methylhydroxychalcone polymer, beta-sitosterol, curcumin and mixtures thereof. It is suitable for use in the preventive and curative treatment of obesity, diabetes, dyslipidaemias, infections caused by infectious agents and the consequences thereof, and in invasive cancers, in particular those associated with adipose tissues.
IPC 8 full level
A61K 31/015 (2006.01); A61K 31/11 (2006.01); A61K 31/12 (2006.01); A61K 31/366 (2006.01); A61K 31/56 (2006.01); A61K 31/575 (2006.01); A61P 3/00 (2006.01); A61P 9/00 (2006.01); A61P 25/00 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/015 (2013.01 - EP US); A61K 31/045 (2013.01 - US); A61K 31/11 (2013.01 - EP US); A61K 31/12 (2013.01 - EP US); A61K 31/353 (2013.01 - US); A61K 31/366 (2013.01 - EP); A61K 31/56 (2013.01 - EP); A61K 31/575 (2013.01 - EP US); A61K 45/06 (2013.01 - US); A61P 3/00 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); Y02A 50/30 (2017.12 - EP)
Citation (search report)
See references of WO 2018127748A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018127748 A1 20180712; CN 110139643 A 20190816; EP 3565536 A1 20191113; FR 3061658 A1 20180713; FR 3061659 A1 20180713; FR 3061659 B1 20200221; US 2020268770 A1 20200827
DOCDB simple family (application)
IB 2017057731 W 20171207; CN 201780082728 A 20171207; EP 17825613 A 20171207; FR 1770014 A 20170107; FR 1771175 A 20171107; US 201716481853 A 20171207